Head of Precision Medicine, Cancer Research UK
After obtaining a PhD in developing targeted PET imaging agents, Rowena worked for Cancer Research UK for five years until 2012. During this time she carried out a large change programme with the Children’s Cancer and Leukaemia Group (CCLG), oversaw the management of early phase trial grants and carried out several strategic reviews, including the future of biomarker driven clinical trials. In the latter period of her time at CRUK she ran Phase One of the CRUK Stratified Medicine Programme.
In 2012 she joined the Royal Marsden NHS Foundation Trust as their NIHR BRC Assistant Director where she set up a new method for awarding and monitoring funding internally, set up the new Royal Marsden Clinical Trials Unit, oversaw the Generic Biobank and led on Royal Marsden involvement in initiatives such as Genomics England.
She re-joined CRUK in 2015 as their Head of Precision Medicine where she has responsibility for leading on the Charity’s agenda in this area and ensuring that Phase Two of the CRUK Stratified Medicine Programme delivers and evolves.